| AMEFX | FAASX | AMEFX / FAASX | |
| Total Expense Ratio | 0.37 | 0.92 | 40% |
| Annual Report Gross Expense Ratio | 0.37 | 0.95 | 39% |
| Fund Existence | 17 years | 17 years | - |
| Gain YTD | 9.676 | 18.532 | 52% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 250 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 140B | 7.71B | 1,816% |
| Annual Yield % from dividends | 3.69 | 1.32 | 279% |
| Returns for 1 year | 8.96 | 13.74 | 65% |
| Returns for 3 years | 28.15 | 41.43 | 68% |
| Returns for 5 years | 29.21 | 31.13 | 94% |
| Returns for 10 years | 54.50 | 84.68 | 64% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MCYCX | 12.75 | 0.06 | +0.47% |
| NYLI Candriam Emerging Markets Eq Cl C | |||
| GSRCX | 11.18 | 0.05 | +0.45% |
| Goldman Sachs Rising Dividend Gr C | |||
| GVIRX | 18.32 | 0.05 | +0.27% |
| Goldman Sachs US Eq Div and Premium Inv | |||
| RRBGX | 190.06 | 0.39 | +0.21% |
| T. Rowe Price Blue Chip Growth R | |||
| NRIIX | 22.43 | 0.03 | +0.13% |
| Nuveen Real Asset Income I | |||